Effect of PSC 833 on the cytotoxicity of idarubicin and idarubicinol in multidrug-resistant K562 cells
- 1 January 1999
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 23 (1) , 37-42
- https://doi.org/10.1016/s0145-2126(98)00138-6
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 24 references indexed in Scilit:
- Section Review Oncologic, Endocrine & Metabolic: Recent developments with novel anthracyclines for the treatment of haematological malignanciesExpert Opinion on Investigational Drugs, 1996
- Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistanceBiochemical Pharmacology, 1995
- Influence of idarubicinol on the antileukemic effect of idarubicinLeukemia Research, 1994
- Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell linesBiochemical Pharmacology, 1994
- Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemiaLeukemia Research, 1994
- Cyclosporins as drug resistance modifiersBiochemical Pharmacology, 1992
- Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26Biochemistry, 1988
- MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPYJapanese Journal of Cancer Research, 1988
- Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.Journal of Clinical Investigation, 1986
- High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivativeJournal of Chromatography B: Biomedical Sciences and Applications, 1983